These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients. Song A, Eo W, Lee S. World J Gastroenterol; 2015 Nov 21; 21(43):12410-20. PubMed ID: 26604648 [Abstract] [Full Text] [Related]
5. Prognostic Value of Preoperative Nutritional and Immunological Factors in Patients with Pancreatic Ductal Adenocarcinoma. Abe T, Nakata K, Kibe S, Mori Y, Miyasaka Y, Ohuchida K, Ohtsuka T, Oda Y, Nakamura M. Ann Surg Oncol; 2018 Dec 21; 25(13):3996-4003. PubMed ID: 30225838 [Abstract] [Full Text] [Related]
7. Prognostic indicators based on inflammatory and nutritional factors after pancreaticoduodenectomy for pancreatic cancer. Watanabe J, Otani S, Sakamoto T, Arai Y, Hanaki T, Amisaki M, Tokuyasu N, Honjo S, Ikeguchi M. Surg Today; 2016 Nov 21; 46(11):1258-67. PubMed ID: 26869184 [Abstract] [Full Text] [Related]
9. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101. He CB, Lin XJ. PLoS One; 2017 Nov 21; 12(3):e0174769. PubMed ID: 28355305 [Abstract] [Full Text] [Related]
13. Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer. Tong YS, Tan J, Zhou XL, Song YQ, Song YJ. J Transl Med; 2017 Oct 31; 15(1):221. PubMed ID: 29089030 [Abstract] [Full Text] [Related]